References
- De Pauw B, Walsh TJ, Donnelly JP, . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
- Warnock DW, Hajjeh RA, Lasker BA. Epidemiology and prevention of invasive aspergillosis. Curr Infect Dis Rep 2001; 3: 507–516.
- Leeflang MM, Debets-Ossenkopp YJ, Visser CE, . Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008; 4: CD007394.
- Maertens J, Van Eldere J, Verhaegen J, . Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297–1306.
- Kontoyiannis DP, Marr KA, Park BJ, . Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091–1100.
- Perkhofer S, Lass-Florl C, Hell M, . The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents 2010; 36: 531–536.
- Hoenigl M, Valentin T, Salzer HJ, Zollner-Schwetz I, Krause R. Underestimating the real burden of invasive fungal infections in hematopoietic stem cell transplant recipients? Clin Infect Dis 2010; 51: 253–254; author reply 254–255.
- Hoenigl M, Zollner-Schwetz I, Sill H, . Epidemiology of invasive fungal infections and rational for antifungal therapy in patients with haematological malignancies. Myc 2011; 54: 454–459.
- Hadrich I, Mary C, Makni F, . Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies. Med Mycol 2011; 49: 489–494.
- Orlopp K, von Lilienfeld-Toal M, Marklein G, . False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem? J Antimicrob Chemother 2008; 62: 1109–1112.
- Arendrup MC, Mavridou E, Mortensen KL, . Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One 2010; 5: e10080.